stella
beta
Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer — Stella
Recruiting
Back to Extensive Stage Small Cell Lung Cancer (ES-SCLC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Chongqing University Affiliated Cancer Hospital, Chongqing, Chongqing Municipality
View full record on ClinicalTrials.gov